New trends in molecular and cellular biomarker discovery for colorectal cancer - Test2 - elhamkhani - TriplyDB

New trends in molecular and cellular biomarker discovery for colorectal cancer

New trends in molecular and cellular biomarker discovery for colorectal cancer

http://www.wikidata.org/entity/Q26739049

about

Longitudinal Analysis of Serum Autoantibody-Reactivities in Patients with Primary Open Angle Glaucoma and Optic Disc Hemorrhage.Dual specificity phosphatase 5 is a novel prognostic indicator for patients with advanced colorectal cancer.Potential role of miR-139-5p in cancer diagnosis, prognosis and therapy Genetic and epigenetic markers in colorectal cancer screening: recent advances.Systematic literature review and clinical validation of circulating microRNAs as diagnostic biomarkers for colorectal cancer Tracing and targeting cancer stem cells: New venture for personalized molecular cancer therapy.Current Tissue Molecular Markers in Colorectal Cancer: A Literature Review.Mir-29b promotes human aortic valve interstitial cell calcification via inhibiting TGF-β3 through activation of wnt3/β-catenin/Smad3 signaling.Circulating mitochondrial stress 70 protein/mortalin and cytosolic Hsp70 in blood: Risk indicators in colorectal cancer.Serum microRNA signatures and metabolomics have high diagnostic value in colorectal cancer using two novel methods.Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review).New localization and function of calpain-2 in nucleoli of colorectal cancer cells in ribosomal biogenesis: effect of KRAS status.miR-888 functions as an oncogene and predicts poor prognosis in colorectal cancer.Aberrantly Expressed Genes and miRNAs in Slow Transit Constipation Based on RNA-Seq Analysis

P2860

Q36234565-32EFEA15-CB94-40FE-8EFD-0ABC09258C5B Q37382545-E391CDCF-0443-46E2-8AD9-09968F16B02B Q38645381-AD658AB5-D25F-49CD-80C6-0863692D2410 Q38676702-0367A004-337E-42CA-99C4-CAF8AB542094 Q42157952-ADCF9B2C-E4A8-4BE1-886D-599F9FC0F54F Q43258268-B7D6DB2B-75FC-4641-8651-F0634409F7AF Q47094355-C69D17B7-4AFA-4EF3-9454-6B1F7FBCEEB3 Q47308479-1659D54F-E284-4B1A-A2A6-6CD85F4EBEEF Q47974707-A33EB514-83FF-4C54-B247-37E13C38586C Q49834015-6D5DF105-4063-47FC-A000-44CAB99CA82B Q51732351-4A67E23F-6016-416D-8D91-F6CEA3C7FD68 Q51744124-CB6A4FC8-3F0C-438A-9752-F10EA42802AF Q55310838-39A8571A-3D9E-4162-BEE8-645BA58F57AA Q58780488-7998F668-E2C9-45B0-9BD5-87DFC90B43E8

P2860

New trends in molecular and cellular biomarker discovery for colorectal cancer

http://www.wikidata.org/entity/Q26739049

description

2016 nî lūn-bûn

@nan

2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

New trends in molecular and cellular biomarker discovery for colorectal cancer

@ast

New trends in molecular and cellular biomarker discovery for colorectal cancer

@en

New trends in molecular and cellular biomarker discovery for colorectal cancer

@nl

type

label

New trends in molecular and cellular biomarker discovery for colorectal cancer

@ast

New trends in molecular and cellular biomarker discovery for colorectal cancer

@en

New trends in molecular and cellular biomarker discovery for colorectal cancer

@nl

prefLabel

New trends in molecular and cellular biomarker discovery for colorectal cancer

@ast

New trends in molecular and cellular biomarker discovery for colorectal cancer

@en

New trends in molecular and cellular biomarker discovery for colorectal cancer

@nl

P1433

Q26739049-AA6E8D22-527A-4658-8F7D-69BEF4A56B1F

P1476

Q26739049-B457F2B9-4FAF-433E-9570-2F71C553A7F2

P2093

Q26739049-1CE03F83-3796-43E3-AE5A-EF4E6E2D6989

P2860

Q26739049-00A92D38-08ED-4BC9-844C-D05C926F28E0

Q26739049-0195CD34-A01E-4F04-B98F-5915B8A237BF

Q26739049-02F527FB-63F9-41A5-9D28-E27C967916A4

Q26739049-03A10414-B0EF-4F0D-846B-7ECE82257CA8

Q26739049-05F1A30C-A933-4549-85D6-41E901878F7E

Q26739049-09778C77-4F96-4712-8C39-A6528AC94681

Q26739049-099D78B5-0E9C-4491-8174-244CBCADA9DD

Q26739049-0A3F8B57-1D00-4F81-9B83-20E0DA74F931

Q26739049-0A8EAFF5-0073-4BDA-9BAA-8F6C69C4047E

Q26739049-0D3A43A9-65CC-494A-9FD7-1806FF8F47C5

P304

Q26739049-7DA0BF2B-14E6-48C2-AA6B-32E4C7272595

P31

Q26739049-2F20F08B-7198-4F84-A448-63DB6FB4756D

P356

Q26739049-EEB4060E-7CE1-4A68-88ED-EBAFDA1C51BD

P407

Q26739049-E2E49F3A-AB60-40F6-A9D1-78541ED2DAE4

P433

Q26739049-54C0399A-DE83-464D-83A9-D196695AACF6

P478

Q26739049-E57A5934-1080-4FE4-BD49-5ED5FFC1D46D

P50

Q26739049-9F9F70B3-B762-4C43-83D0-1BB27C4381C2

P577

Q26739049-E3083F8C-11EB-48BD-84C0-0DAAF3CA7CDE

P698

Q26739049-1D55CC50-98FB-4F41-9E71-3B4E25E9BE81

P921

Q26739049-9121F910-7B36-4C70-9A6E-26F2570F6930

Q26739049-ECD63A8F-2D4F-495A-9209-D07013B64256

P932

Q26739049-185BF0C9-9EB5-4E95-85E8-830F3047A35B

P356

WJG.V22.I25.5678

P1433

World Journal of Gastroenterology

P1476

New trends in molecular and cellular biomarker discovery for colorectal cancer

@en

P2093

Parisa Aghagolzadeh

http://www.w3.org/2001/XMLSchema#string

P2860

BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status.

Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas

Molecular origins of cancer: Molecular basis of colorectal cancer

Comprehensive molecular characterization of human colon and rectal cancer

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers

Fecal DNA testing for colorectal cancer screening: Molecular targets and perspectives

Micro-RNAs as potential new molecular biomarkers in oncology: have they reached relevance for the clinical imaging sciences?

Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

P304

5678-5693

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V22.I25.5678

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27433083

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

4932205

http://www.w3.org/2001/XMLSchema#string